Electrospider in the final at the National Innovation Award
The Electrospider bioprinter won a place in the final for the "National Award for Innovation" (PNI), after taking first place in the Start Cup Toscana 2022, the regional competition that rewarded innovative and technological ideas. The PNI is the most important business plan competition in Italy. The last act of the competition will be held in L'Aquila on 1 December.
Electrospider is an innovative 3D biofabrication technology patented by Bio3DPrinting, a company born from the collaboration between SolidWorld GROUP and the University of Pisa, capable of generating 3D cellular constructs having the complex topology of human tissues. The bioprinter represents an epochal evolution in the medical, pharmaceutical and cosmetic fields.
The goal of Electrospider is to use cells taken from the patient to bioprint perfectly functional organs. This allows to solve the problems related to the limited availability of organs for transplants.
Related posts

Con Bio3DPrinting la stampa 3D entra nella chirurgia pediatrica ad alta complessità
Realizzato un innovativo modello anatomico tridimensionale di un fegato utilizzato per la pianificazione di un delicato intervento chirurgico in uno dei principali ospedali pediatrici italiani.

Il futuro di Electrospider – Intervista ad Aurora De Acutis, CEO di Bio3DPrinting
In questa intervista Aurora De Acutis racconta quali sono le attuali applicazioni di Electrospider e la sua visione futura dei trapianti con tessuti e organi biostampati.

Electrospider realizza un modello tracheale biomimetico
La biostampa 3D segna un nuovo passo verso la medicina rigenerativa